Cargando…

Letter: Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle.

Detalles Bibliográficos
Autores principales:	Smith, B. J., Kundv, D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1976
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024933/ https://www.ncbi.nlm.nih.gov/pubmed/1259917

Ejemplares similares

The effect of digoxin on the binding of adriamycin to cat heart muscle.
por: Somberg, J., et al.
Publicado: (1977)

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
por: Wang, Yingying, et al.
Publicado: (2020)

Inappropriate use of digoxin in patients presenting with digoxin toxicity
por: Tatlisu, Mustafa Adem, et al.
Publicado: (2015)

The effect of different digoxin concentrations on heart tissue and antioxidant status in iron-overloaded rats
por: Shahouzehi, Beydolah, et al.
Publicado: (2018)

The effect of digoxin on renal function in patients with heart failure
por: Shah, Parin, et al.
Publicado: (2021)

Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
por: Gerakaris, Andreas, et al.
Publicado: (2022)

Adipocyte metabolism of the chemotherapy daunorubicin
por: Mittelman, Steven D., et al.
Publicado: (2018)

Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells.
por: Ganapathi, R., et al.
Publicado: (1986)

Adriamycin does not damage podocytes of zebrafish larvae
por: Schindler, Maximilian, et al.
Publicado: (2020)

Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable?
por: Saad, Antonio F., et al.
Publicado: (2016)

Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemia.
por: Smith, B. J., et al.
Publicado: (1976)

Use of digoxin-specific antibody fragments (Fab) in the management of digoxin poisoning.
por: Brown, J. H., et al.
Publicado: (1986)

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
por: Sehested, M., et al.
Publicado: (1987)

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats
por: Sari, Flori R., et al.
Publicado: (2011)

Different distribution of adriamycin in normal and leukaemic rats.
por: Sonneveld, P., et al.
Publicado: (1981)

Efficacy and safety of digoxin in acute heart failure triggered by tachyarrhythmia
por: Shrestha, Samyut, et al.
Publicado: (2022)

Chronic Digoxin Toxicity: An Evaluation of Digoxin-Specific Antibodies and Other Management Options
por: Clifford, Liam M, et al.
Publicado: (2023)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
por: Colella, Antonella, et al.
Publicado: (2022)

Inhibition of Cyclooxygenase-2 Reduces Hypothalamic Excitation in Rats with Adriamycin-Induced Heart Failure
por: Zheng, Min, et al.
Publicado: (2012)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Observational cohort study of the safety of digoxin use in women with heart failure
por: Flory, James H, et al.
Publicado: (2012)

Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure
por: Bavendiek, Udo, et al.
Publicado: (2017)

Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
por: Parikh, Riya R, et al.
Publicado: (2022)

Potential Effects of Digoxin on Renal Functions in Patients With Congestive Heart Failure
por: Alqahtani, Mesfer A, et al.
Publicado: (2023)

Liposomal daunorubicin as treatment for Kaposi’s sarcoma
por: Petre, Christin E, et al.
Publicado: (2007)

Interactions of Cisplatin and Daunorubicin at the Chromatin Level
por: Firouzi Niaki, Erfaneh, et al.
Publicado: (2020)

Neglected facts in digoxin intoxication
por: Serin, Sibel Ocak
Publicado: (2017)

‘Digoxin conundrum – Time for validation?’
por: Yadava, O.P.
Publicado: (2021)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Enhanced sympathetic activity and cardiac sympathetic afferent reflex in rats with heart failure induced by adriamycin
por: Zhang, Shujuan, et al.
Publicado: (2012)

Effects of digoxin on cardiac iron content in rat model of iron overload
por: Nasri, Hamid Reza, et al.
Publicado: (2016)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Digoxin in management of heart failure in children: Should it be continued or relegated to the history books?
por: Jain, Shreepal, et al.
Publicado: (2009)

Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction
por: Zhou, Jingmin, et al.
Publicado: (2020)

Effects of adriamycin and candesartan on the collagen and elastin of the aorta in rats
por: Uhm, Jae-Sun, et al.
Publicado: (2014)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model
por: Hong, Young Mi, et al.
Publicado: (2017)

Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats
por: Zhang, Wei, et al.
Publicado: (2008)

Heart Transplantation for Adriamycin Cardiomyopathy: The Plural of Anecdote and the Power of Registries
por: Kittleson, Michelle M.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sqepi3lfuj4i5qr9n77bv67k4q